Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.

Conventional vehicle suspension systems, often relying on integer-order models with fixed damping coefficients, struggle to deliver optimal performance across diverse an ...